Show Summary Details
Page of

(p. 699) Pharmacotherapy and Psychotherapy for Sexual Dysfunctions 

(p. 699) Pharmacotherapy and Psychotherapy for Sexual Dysfunctions
Chapter:
(p. 699) Pharmacotherapy and Psychotherapy for Sexual Dysfunctions
Author(s):

R. Taylor Segraves

DOI:
10.1093/med:psych/9780199342211.003.0022
Page of

PRINTED FROM OXFORD CLINICAL PSYCHOLOGY ONLINE (www.oxfordclinicalpsych.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Clinical Psychology Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 October 2020

Well-controlled, double-blind, multisite investigations have demonstrated the efficacy of phosphodiesterase type 5 inhibitors for the treatment of erectile problems of mixed etiologies. A large number of studies affirm that serotonergic antidepressants delay ejaculation in men with premature ejaculation. Similarly, studies have demonstrated the efficacy of transdermal testosterone therapy in restoring sexual function in women after oophorectomy. There is suggestive evidence of the efficacy of cognitive-behavioral therapy in the treatment of sexual dysfunction in both sexes. However, the number and methodological rigor of such studies are limited and the effect sizes tend to be smaller than studies of pharmacological therapies.

Access to the complete content on Oxford Clinical Psychology requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.